JP2025503176A5 - - Google Patents
Info
- Publication number
- JP2025503176A5 JP2025503176A5 JP2024544412A JP2024544412A JP2025503176A5 JP 2025503176 A5 JP2025503176 A5 JP 2025503176A5 JP 2024544412 A JP2024544412 A JP 2024544412A JP 2024544412 A JP2024544412 A JP 2024544412A JP 2025503176 A5 JP2025503176 A5 JP 2025503176A5
- Authority
- JP
- Japan
- Prior art keywords
- administered
- day
- pharmaceutical composition
- composition according
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263304424P | 2022-01-28 | 2022-01-28 | |
| US63/304,424 | 2022-01-28 | ||
| PCT/EP2023/051979 WO2023144290A1 (en) | 2022-01-28 | 2023-01-27 | Bispecific antibody against cd3 and cd20 in combination therapy for treating diffuse large b-cell lymphoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503176A JP2025503176A (ja) | 2025-01-30 |
| JP2025503176A5 true JP2025503176A5 (enExample) | 2026-02-10 |
Family
ID=85158800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544412A Pending JP2025503176A (ja) | 2022-01-28 | 2023-01-27 | びまん性大細胞型ｂ細胞リンパ腫を治療するための併用療法におけるｃｄ３及びｃｄ２０に対する二重特異性抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20250115665A1 (enExample) |
| EP (1) | EP4469082A1 (enExample) |
| JP (1) | JP2025503176A (enExample) |
| KR (1) | KR20240135663A (enExample) |
| CN (1) | CN118613281A (enExample) |
| AU (1) | AU2023214116A1 (enExample) |
| CA (1) | CA3243415A1 (enExample) |
| IL (1) | IL314344A (enExample) |
| MX (1) | MX2024008833A (enExample) |
| TW (1) | TW202345895A (enExample) |
| WO (1) | WO2023144290A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230008775A (ko) | 2020-05-08 | 2023-01-16 | 젠맵 에이/에스 | Cd3 및 cd20에 대한 이중특이적 항체 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| GB9203459D0 (en) | 1992-02-19 | 1992-04-08 | Scotgen Ltd | Antibodies with germ-line variable regions |
| EP0979281B1 (en) | 1997-05-02 | 2005-07-20 | Genentech, Inc. | A method for making multispecific antibodies having heteromultimeric and common components |
| KR100944575B1 (ko) | 2002-10-17 | 2010-02-25 | 젠맵 에이/에스 | Ｃｄ20에 대한 인간 모노클로날 항체 |
| US7741568B2 (en) | 2005-01-13 | 2010-06-22 | The Wiremold Company | Downward facing receptacle assembly for cable raceway |
| KR101374454B1 (ko) | 2005-03-31 | 2014-03-17 | 추가이 세이야쿠 가부시키가이샤 | 회합제어에 의한 폴리펩티드 제조방법 |
| KR101866623B1 (ko) | 2005-11-28 | 2018-07-04 | 젠맵 에이/에스 | 재조합 １가 항체 및 그의 제조 방법 |
| EP3663318A1 (en) | 2008-01-07 | 2020-06-10 | Amgen Inc. | Method for making antibody fc-heterodimeric molecules using electrostatic steering effects |
| US9067986B2 (en) | 2009-04-27 | 2015-06-30 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| TWI426920B (zh) | 2010-03-26 | 2014-02-21 | Hoffmann La Roche | 雙專一性、雙價抗－ｖｅｇｆ／抗－ａｎｇ－２抗體 |
| PT2560993T (pt) | 2010-04-20 | 2024-09-16 | Genmab As | Proteínas contendo anticorpo heterodimérico fc e métodos para a produção das mesmas |
| IN2014CN03887A (enExample) | 2011-10-27 | 2015-10-16 | Genmab As | |
| KR102813816B1 (ko) | 2013-07-05 | 2025-05-29 | 젠맵 에이/에스 | 인간화 또는 키메라 cd3 항체 |
| US20170128448A1 (en) * | 2014-07-11 | 2017-05-11 | Celgene Corporation | Combination therapy for cancer |
| CN107660214B (zh) | 2015-01-08 | 2022-02-08 | 根马布股份公司 | 针对cd3和cd20的双特异性抗体 |
| BR112020015052A2 (pt) | 2018-02-09 | 2020-12-08 | Genmab A/S | Composição farmacêutica, uso da composição farmacêutica, métodos para tratar câncer em um sujeito, para preparar uma composição farmacêutica e para preparar uma forma de dosagem unitária, forma de dosagem unitária, recipiente, e, kit-de-partes |
| BR112021009420A2 (pt) * | 2018-11-16 | 2021-11-23 | Juno Therapeutics Inc | Métodos de dosagem de células t manipuladas para o tratamento de malignidades de células b |
| IL301086A (en) * | 2020-09-10 | 2023-05-01 | Genmab As | Bispecific antibody against cd3 and cd20 in combination therapy for treating follicular lymphoma |
-
2023
- 2023-01-27 CA CA3243415A patent/CA3243415A1/en active Pending
- 2023-01-27 KR KR1020247028130A patent/KR20240135663A/ko active Pending
- 2023-01-27 EP EP23702966.5A patent/EP4469082A1/en active Pending
- 2023-01-27 CN CN202380018858.8A patent/CN118613281A/zh active Pending
- 2023-01-27 MX MX2024008833A patent/MX2024008833A/es unknown
- 2023-01-27 US US18/833,261 patent/US20250115665A1/en active Pending
- 2023-01-27 WO PCT/EP2023/051979 patent/WO2023144290A1/en not_active Ceased
- 2023-01-27 US US18/160,386 patent/US20230241211A1/en active Pending
- 2023-01-27 JP JP2024544412A patent/JP2025503176A/ja active Pending
- 2023-01-27 AU AU2023214116A patent/AU2023214116A1/en active Pending
- 2023-01-27 IL IL314344A patent/IL314344A/en unknown
- 2023-01-30 TW TW112103163A patent/TW202345895A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023541860A5 (enExample) | ||
| JP2023542289A5 (enExample) | ||
| JP2023541858A5 (enExample) | ||
| JP2023542290A5 (enExample) | ||
| JP2023524149A5 (enExample) | ||
| JP2025138634A (ja) | Ｂ細胞成熟抗原を標的にする多重特異性抗体のための投与計画及び組み合わせ治療 | |
| JP2023542092A5 (enExample) | ||
| JP2021501162A5 (enExample) | ||
| JP2023542291A5 (enExample) | ||
| JP6278536B2 (ja) | 関節炎治療 | |
| JP2021514973A5 (enExample) | ||
| JP2025032102A5 (enExample) | ||
| JP2020536097A5 (enExample) | ||
| CA2648223A1 (en) | Use of il-i antibodies for treating ophthalmic disorders | |
| JP2009532336A5 (enExample) | ||
| US20230227570A1 (en) | Bispecific antibodies against cd3 and cd20 | |
| JP2024534602A5 (enExample) | ||
| JP2022512875A5 (enExample) | ||
| CN112480259B (zh) | 抗tnfr2抗体及其用途 | |
| JP2021507677A (ja) | 抗ｔｒｋｂモノクローナル抗体および使用の方法 | |
| JP2023526233A (ja) | 抗ｇｌｐ１ｒアンタゴニスト抗体およびその使用方法 | |
| US20240368290A1 (en) | Tmem219 antibodies and therapeutic uses thereof | |
| JP2024540435A5 (enExample) | ||
| JP2023510199A5 (enExample) | ||
| JP2020505350A5 (enExample) |